Detection of serum HER2 in patients treated with neratinib or trastuzumab: analysis of the I-SPY Trial.

Hensley M, Lengfeld J, Stoesz S, Edwards M, Pass F, Hirst GL, Brown-Swigart L, van 't Veer L, Esserman LJ, Beckwith H, Yee D

Open source

DOI: 10.3389/fonc.2025.1605120
Published: 2025
Container: Frontiers in oncology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fonc.2025.1605120,
  title = {Detection of serum HER2 in patients treated with neratinib or trastuzumab: analysis of the I-SPY Trial.},
  author = {Hensley M and Lengfeld J and Stoesz S and Edwards M and Pass F and Hirst GL and Brown-Swigart L and van 't Veer L and Esserman LJ and Beckwith H and Yee D},
  year = {2025},
  journal = {Frontiers in oncology},
  doi = {10.3389/fonc.2025.1605120},
  url = {https://doi.org/10.3389/fonc.2025.1605120}
}

RIS

TY  - JOUR
TI  - Detection of serum HER2 in patients treated with neratinib or trastuzumab: analysis of the I-SPY Trial.
AU  - Hensley M
AU  - Lengfeld J
AU  - Stoesz S
AU  - Edwards M
AU  - Pass F
AU  - Hirst GL
AU  - Brown-Swigart L
AU  - van 't Veer L
AU  - Esserman LJ
AU  - Beckwith H
AU  - Yee D
PY  - 2025
JO  - Frontiers in oncology
DO  - 10.3389/fonc.2025.1605120
UR  - https://doi.org/10.3389/fonc.2025.1605120
ER  -

APA

M, H., J, L., S, S., M, E., F, P., GL, H., L, B., L, V. '. V., LJ, E., H, B., & D, Y. (2025). Detection of serum HER2 in patients treated with neratinib or trastuzumab: analysis of the I-SPY Trial.. Frontiers in oncology. https://doi.org/10.3389/fonc.2025.1605120

Source records

pubmed · retrieved 2026-09-26T21:47:07.835Z